Literature DB >> 21544542

MicroRNAs as biomarkers of disease onset.

Maciej Ciesla1, Klaudia Skrzypek, Magdalena Kozakowska, Agnieszka Loboda, Alicja Jozkowicz, Jozef Dulak.   

Abstract

MicroRNAs (miRNAs) are small, noncoding RNA molecules with the ability to posttranscriptionally regulate gene expression via targeting the 3' untranslated region of messenger RNAs. miRNAs are critical for normal cellular functions such as the regulation of the cell cycle, differentiation, and apoptosis, and they target genes during embryonal and postnatal development, whereas their expression is unbalanced in various pathological states. Importantly, miRNAs are abundantly present in body fluids (e.g., blood), which are routinely examined in patients. These molecules circulate in free and exosome encapsulated forms, and can be efficiently detected and amplified by means of molecular biology tools such as real-time PCR. Together with relative stability, specificity, and reproducibility, they are seen as good candidates for early recognition of the onset of disease. Thus, miRNAs might be considered as biomarkers for many pathological states. © Springer-Verlag 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544542     DOI: 10.1007/s00216-011-5001-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  34 in total

1.  Muscle Decline in Aging and Neuromuscular Disorders - Mechanisms and Countermeasures: Terme Euganee, Padova (Italy), April 13-16, 2016.

Authors: 
Journal:  Eur J Transl Myol       Date:  2016-03-31

2.  Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.

Authors:  Magdalena Kozakowska; Krzysztof Szade; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

3.  Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.

Authors:  Gabor Lendvai; Katalin Jármay; Gizella Karácsony; Tünde Halász; Ilona Kovalszky; Kornélia Baghy; Tibor Wittmann; Zsuzsa Schaff; András Kiss
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction.

Authors:  Junjie Xiao; Bo Shen; Jin Li; Dongcao Lv; Yingying Zhao; Fei Wang; Jiahong Xu
Journal:  Int J Clin Exp Med       Date:  2014-01-15

5.  miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan.

Authors:  Tünde Halász; Gábor Horváth; Gabriella Pár; Klára Werling; András Kiss; Zsuzsa Schaff; Gábor Lendvai
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

6.  MicroRNA expression might predict prognosis of epithelial hepatoblastoma.

Authors:  Mónika Gyugos; Gábor Lendvai; István Kenessey; Krisztina Schlachter; Judit Halász; Péter Nagy; Miklós Garami; Zsuzsa Jakab; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

7.  Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.

Authors:  Yeyi Yang; Li Xiao; Jun Li; Yashpal S Kanwar; Fuyou Liu; Lin Sun
Journal:  Med Hypotheses       Date:  2013-05-14       Impact factor: 1.538

Review 8.  MicroRNAs in cancer diagnosis and therapy: from bench to bedside.

Authors:  Isamu Hoshino; Hisahiro Matsubara
Journal:  Surg Today       Date:  2012-11-06       Impact factor: 2.549

9.  Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure.

Authors:  John J Gildea; Julia M Carlson; Cynthia D Schoeffel; Robert M Carey; Robin A Felder
Journal:  Clin Biochem       Date:  2013-05-29       Impact factor: 3.281

Review 10.  Circulating microRNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke.

Authors:  W Y Li; J Jin; J Chen; Y Guo; J Tang; S Tan
Journal:  J Hum Hypertens       Date:  2013-10-17       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.